TINAVI(688277)2023-11-27 10:44Financial Performance - The company aims to achieve breakeven through product line expansion and continuous innovation [2][3] - Disposable specialized consumables currently account for a low but growing percentage of revenue [3][4] Product Offerings - The main orthopedic surgical robots promoted are the Tianji series, covering trauma, spine, and joint fields [4][5] - The company has obtained medical device registration for a multi-indication machine, which includes various spinal and joint surgeries [5][6] Market Position - The company’s orthopedic surgical robots have a leading market share in China, with a rapid increase in acceptance among doctors and patients [5][6] - As of September 30, 2023, the company has conducted over 50,000 surgeries using its robotic systems [6][7] Competitive Landscape - Several domestic and international competitors have obtained Class III medical device registration in China, including major players in the spine and joint categories [6][7]